Explore

Reuters Reuters
Eli Lilly's weight-loss pill secures first European nod in Britain

Eli Lilly's weight-loss pill secures first European nod in Britain

By Padmanabhan Ananthan Aug 10 (Reuters) - Britain's medicines regulator on Monday authorised Eli Lilly's pill Foundayo for weight management and type 2 diabetes, making it the first country in Europe to green light the treatment.
Reuters Reuters
Rocket Lab flags weaker quarterly margins as lower-profit satellite sales increase

Rocket Lab flags weaker quarterly margins as lower-profit satellite sales increase

Aug 10 (Reuters) - Rocket Lab forecast third-quarter gross margin below Wall Street expectations on Monday, as sales of lower-margin satellite platforms are set to make up a larger share of its business.
Reuters Reuters
Factbox-Global drugmakers invest billions to boost US presence

Factbox-Global drugmakers invest billions to boost US presence

Aug 10 (Reuters) - Global drugmakers are expanding their U.S. footprint, pledging billions of dollars to ramp up manufacturing capacity and research in the country.
Reuters Reuters
Trading platform Plus500 reports higher core profit as US business gains traction

Trading platform Plus500 reports higher core profit as US business gains traction

Aug 10 (Reuters) - Trading platform Plus500 reported a rise in half-year core profit on Monday, aided by higher trading activity as the company expanded its U.S. business and rolled out more products, including the fast-growing predictions market.
Trendline Trendline
Novo Nordisk Raises 2026 Outlook Amid Strong Q2 Sales Performance

Novo Nordisk Raises 2026 Outlook Amid Strong Q2 Sales Performance

Novo Nordisk Raises 2026 Outlook Amid Strong Q2 Sales Performance
Reuters Reuters
Taylor Farms recalls salsa, guacamole on salmonella outbreak, intensifying food-safety fears

Taylor Farms recalls salsa, guacamole on salmonella outbreak, intensifying food-safety fears

By Juveria Tabassum and Angela Christy M Aug 10 (Reuters) - Taylor Farms is recalling prepared foods containing jalapenos from retailers including Walmart, Kroger and Whole Foods in several states over potential salmonella contamination, the second major foodborne illness linked to the produce
Reuters Reuters
Teledyne to acquire Varex Imaging in $1.1 billion deal

Teledyne to acquire Varex Imaging in $1.1 billion deal

Aug 10 (Reuters) - Sensing-systems maker Teledyne Technologies agreed to acquire Varex Imaging for $18.90 per share in an all-cash transaction valued at approximately $1.1 billion, the companies said on Monday. Shares of X-ray imaging components maker Varex jumped nearly 50% before the bell.
Trendline Trendline
RadNet Reports Record Revenue and Adjusted EBITDA in Q2 2026

RadNet Reports Record Revenue and Adjusted EBITDA in Q2 2026

RadNet Reports Record Revenue and Adjusted EBITDA in Q2 2026
Reuters Reuters
Taylor Farms recalls salsa and guacamole from Walmart, Kroger over salmonella risk

Taylor Farms recalls salsa and guacamole from Walmart, Kroger over salmonella risk

Aug 9 (Reuters) - Taylor Farms said on Sunday it was recalling prepared food items containing jalapenos from retailers, including Walmart, Kroger and Whole Foods in some states, over concerns about potential salmonella contamination.
Trendline Trendline
Novo Nordisk CEO Resets Expectations for Wegovy's Growth Amid Market Competition

Novo Nordisk CEO Resets Expectations for Wegovy's Growth Amid Market Competition

Novo Nordisk CEO Resets Expectations for Wegovy's Growth Amid Market Competition
Reuters Reuters
Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs data

Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs data

By Tharuniyaa Lakshmi, Ragini Mathur and Avinash P Aug 7 (Reuters) - Europe's STOXX 600 rallied to a fourth consecutive record close on Friday, led by technology stocks and a largely positive slate of corporate earnings, while softer U.S. jobs data further supported sentiment.
USA Today USA Today
Bank of America spends $250M yearly on GLP-1s for workers, CEO says

Bank of America spends $250M yearly on GLP-1s for workers, CEO says

Bank of America's CEO said the company spends more than $250 million a year on GLP-1 drugs for employees, calling the growing cost a worthwhile investment.